Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. Among authors: hanyok jj. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial.
Geller BJ, Giugliano RP, Braunwald E, Murphy SA, Hanyok JJ, Jin J, Mercuri M, Antman EM, Ruff CT. Geller BJ, et al. Among authors: hanyok jj. Am Heart J. 2015 Oct;170(4):669-74. doi: 10.1016/j.ahj.2015.06.020. Epub 2015 Jul 2. Am Heart J. 2015. PMID: 26386790 Clinical Trial.
Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA. Sung RJ, et al. Among authors: hanyok jj. Am Heart J. 1995 Apr;129(4):739-48. doi: 10.1016/0002-8703(95)90324-0. Am Heart J. 1995. PMID: 7900626 Free article. Clinical Trial.
Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effects.
McClean DR, Ikram H, Mehta S, Heywood JT, Rousseau MF, Niederman AL, Sequeira RF, Fleck E, Singh SN, Coutu B, Hanrath P, Komajda M, Bryson CC, Qian C, Hanyok JJ; Omapatrilat Hemodynamic Study Group. McClean DR, et al. Among authors: hanyok jj. J Am Coll Cardiol. 2002 Jun 19;39(12):2034-41. doi: 10.1016/s0735-1097(02)01881-8. J Am Coll Cardiol. 2002. PMID: 12084605 Free article. Clinical Trial.
Clinical pharmacokinetics of sotalol.
Hanyok JJ. Hanyok JJ. Am J Cardiol. 1993 Aug 12;72(4):19A-26A. doi: 10.1016/0002-9149(93)90021-4. Am J Cardiol. 1993. PMID: 8346722 Review.
Sotalol versus class I and II antiarrhythmic agents.
Hanyok JJ, MacNeil DJ. Hanyok JJ, et al. Cardiovasc Drugs Ther. 1990 Jun;4 Suppl 3:603-11. doi: 10.1007/BF00357038. Cardiovasc Drugs Ther. 1990. PMID: 2275890 Clinical Trial.
16 results